{"url_path":"/sec/sgp/8-k/2026-05-14/item-2-02","section_key":"item-2-02","section_title":"Item 2.02 Results of Operations and Financial Condition","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1778922/0001778922-26-000033-index.html","accession_number":"0001778922-26-000033","cik":"0001778922","ticker":"SGP","issuer_name":"SpyGlass Pharma, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1778922/0001778922-26-000033-index.html","primary_entity_key":"0001778922","primary_entity_name":"SpyGlass Pharma, Inc."},"word_count":116,"has_tables":true,"body_markdown":"Item 2.02. Results of Operations and Financial Condition\n\nOn May 14, 2026, SpyGlass Pharma, Inc. issued a press release announcing its financial results for the quarter ended March 31, 2026. A copy of the press release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K.\n\nThe information furnished pursuant to Item 2.02 and in the accompanying Exhibit 99.1 shall not be deemed \"filed\" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing."}